Clifford Swan Investment Counsel LLC lowered its holdings in shares of Monsanto (NYSE:MON) by 6.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 152,168 shares of the basic materials company’s stock after selling 10,595 shares during the quarter. Clifford Swan Investment Counsel LLC’s holdings in Monsanto were worth $17,770,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also bought and sold shares of the company. Gradient Investments LLC purchased a new position in Monsanto during the 4th quarter valued at $108,000. Americafirst Capital Management LLC purchased a new position in Monsanto during the 3rd quarter valued at $148,000. S&CO Inc. purchased a new position in Monsanto during the 3rd quarter valued at $216,000. McKinley Carter Wealth Services Inc. purchased a new position in Monsanto during the 4th quarter valued at $218,000. Finally, Corundum Group Inc. purchased a new position in Monsanto during the 3rd quarter valued at $228,000. Institutional investors own 74.62% of the company’s stock.
Shares of Monsanto (MON) opened at $120.79 on Friday. Monsanto has a 1-year low of $108.51 and a 1-year high of $123.15. The firm has a market capitalization of $53,240.00, a price-to-earnings ratio of 22.33, a price-to-earnings-growth ratio of 1.73 and a beta of 1.01. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.28 and a quick ratio of 0.79.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Friday, April 6th will be paid a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.79%. The ex-dividend date is Thursday, April 5th. Monsanto’s dividend payout ratio (DPR) is currently 39.93%.
A number of equities analysts recently issued reports on MON shares. Zacks Investment Research cut Monsanto from a “buy” rating to a “hold” rating in a report on Monday, December 11th. Wells Fargo & Co restated a “market perform” rating and set a $128.00 price objective (up previously from $118.00) on shares of Monsanto in a report on Wednesday, January 17th. Deutsche Bank restated a “buy” rating on shares of Monsanto in a report on Tuesday, January 16th. Finally, Royal Bank of Canada restated a “hold” rating and set a $128.00 price objective on shares of Monsanto in a report on Wednesday, November 15th. Eleven investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $127.30.
In related news, EVP Steven Mizell sold 8,100 shares of the company’s stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total transaction of $966,735.00. Following the completion of the sale, the executive vice president now directly owns 56,743 shares in the company, valued at approximately $6,772,277.05. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.79% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Monsanto (MON) Position Cut by Clifford Swan Investment Counsel LLC” was first published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://www.chaffeybreeze.com/2018/02/18/monsanto-mon-position-cut-by-clifford-swan-investment-counsel-llc.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.